Complete Filing Data
agilon health, inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $126.73 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean agilon health, inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$391.3M | -$260.2M | -$262.6M | -$106.6M | -$406.5M | -$60.1M | -$282.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B | $1.22B | $794.4M |
| Operating Income Loss | -$463.2M | -$292.1M | -$232.1M | -$105.4M | -$372.2M | -$56.7M | -$106.6M |
| Nonoperating Income Expense | $67.6M | $34.5M | $27.8M | $13.9M | $2.2M | $2.5M | $955.0K |
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$405.3M | -$250.3M | -$195.3M | -$92.3M | -$383.9M | -$63.2M | -$114.5M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$404.1M | -$248.8M | -$194.5M | -$90.7M | -$383.0M | -$62.3M | -$114.7M |
| General And Administrative Expense | $238.5M | $268.9M | $285.8M | $207.8M | $427.5M | $137.3M | $122.8M |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $50.0K | -$207.0K | -$311.0K | -$300.0K | $0.00 | -$152.0K |
| Income Tax Expense Benefit | $1.3M | $1.5M | $791.0K | $1.6M | $886.0K | $865.0K | -$232.0K |
| Income Loss From Equity Method Investments | -$1.8M | $15.0M | $16.5M | $10.7M | -$6.8M | $514.0K | -$747.0K |
| Income Loss From Continuing Operations Per Diluted Share | -$0.98 | -$0.61 | -$0.48 | -$0.22 | -$1.03 | -$0.20 | |
| Income Loss From Continuing Operations Per Basic Share | -$0.98 | -$0.61 | -$0.48 | -$0.22 | -$1.03 | -$0.20 | |
| Discontinued Operation Income Loss From Discontinued Operation Before Income Tax | |||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$390.3M | -$257.9M | -$259.5M | -$112.4M | -$406.8M | -$60.1M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | $50.0K | -$207.0K | -$311.0K | -$300.0K | $0.00 | |
| Comprehensive Income Net Of Tax | -$390.3M | -$257.9M | -$259.3M | -$112.1M | -$406.5M | -$60.1M | |
| Interest Expense | $6.7M | $4.5M | $6.1M | $8.1M | $9.1M | ||
| Other Comprehensive Income Loss Net Of Tax | $1.0M | $2.2M | $3.3M | -$5.6M | |||
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share | $0.03 | -$0.02 | -$0.16 | -$0.04 | -$0.06 | $0.01 | |
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share | $0.03 | -$0.02 | -$0.16 | -$0.04 | -$0.06 | $0.01 | |
| Income Loss From Discontinued Operations Net Of Tax | -$9.8M | -$67.6M | -$14.6M | -$22.9M | $3.2M | -$168.3M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $44.0K | -$25.0K | $79.0K | $0.00 | $0.00 | ||
| Operating Expenses | $2.83B | $2.23B | $1.28B | $901.0M | |||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $960.0K | $2.2M | $3.2M | -$5.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$110.2M | -$104.4M | $12.1M | -$117.6M | -$30.7M | -$6.1M | -$31.4M | -$16.7M | $16.0M | -$30.7M | -$20.6M | $1.2M | -$35.8M | -$298.8M | -$15.1M | -$11.8M | -$7.9M | -$16.1M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $1.44B | $1.39B | $1.53B | $1.45B | $1.48B | $1.60B | $1.14B | $1.07B | $1.05B | $694.9M | $670.1M | $653.4M | $458.6M | $499.0M | $413.1M | $312.7M | $293.6M | $291.0M | |
| Operating Income Loss | -$131.3M | -$116.0M | -$22.1M | -$133.5M | -$43.3M | -$7.2M | -$39.3M | -$29.0M | $417.0K | -$29.5M | -$21.1M | -$743.0K | -$35.6M | -$298.4M | -$12.1M | -$9.8M | -$1.3M | -$5.8M | |
| Nonoperating Income Expense | $9.4M | $7.9M | $9.3M | $16.1M | $4.8M | $5.9M | $5.4M | $7.1M | $7.9M | $4.9M | $7.0M | $2.3M | -$269.0K | $3.0M | $1.3M | -$469.0K | -$74.0K | $122.0K | |
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$110.2M | -$104.4M | -$1.9M | -$116.4M | -$30.7M | $3.2M | -$22.0M | -$16.0M | $10.0M | -$30.5M | -$21.0M | $726.0K | -$37.0M | -$297.3M | -$13.7M | -$12.3M | -$3.4M | -$7.9M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$110.5M | -$104.3M | -$1.7M | -$117.0M | -$30.2M | $3.1M | -$20.8M | -$15.0M | $8.2M | -$29.9M | -$20.5M | $655.0K | -$36.7M | -$296.9M | -$13.7M | -$12.3M | -$3.4M | -$7.9M | |
| General And Administrative Expense | $56.2M | $56.3M | $66.0M | $63.1M | $69.6M | $76.4M | $72.1M | $79.3M | $69.8M | $52.0M | $51.9M | $39.8M | $46.6M | $317.6M | $37.8M | $30.4M | $34.2M | $27.6M | |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $20.0K | $30.0K | -$47.0K | -$46.0K | -$63.0K | -$71.0K | -$82.0K | $75.0K | $115.0K | $96.0K | -$73.0K | $0.00 | $0.00 | ||
| Income Tax Expense Benefit | -$331.0K | $62.0K | $196.0K | -$590.0K | $417.0K | -$133.0K | $1.2M | $1.1M | -$1.8M | $559.0K | $580.0K | -$71.0K | $256.0K | $435.0K | $16.0K | $35.0K | $39.0K | ||
| Income Loss From Equity Method Investments | $13.1M | $5.4M | $12.7M | $2.0M | $10.0M | $5.7M | $14.7M | $8.5M | $1.4M | -$4.3M | $2.0M | $8.9M | -$3.0K | ||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.27 | -$0.25 | $0.00 | -$0.29 | -$0.07 | $0.01 | -$0.06 | -$0.04 | $0.02 | -$0.07 | -$0.05 | $0.00 | -$0.09 | -$0.79 | |||||
| Income Loss From Continuing Operations Per Basic Share | -$0.27 | -$0.25 | $0.00 | -$0.29 | -$0.07 | $0.01 | -$0.06 | -$0.04 | $0.02 | -$0.07 | -$0.05 | $0.00 | -$0.09 | -$0.79 | |||||
| Discontinued Operation Income Loss From Discontinued Operation Before Income Tax | $0.00 | $0.00 | $0.00 | -$1.2M | $0.00 | -$518.0K | -$9.4M | -$769.0K | -$224.0K | $321.0K | $429.0K | $1.1M | -$1.5M | -$1.4M | $584.0K | -$4.3M | -$8.1M | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$110.1M | -$104.1M | $12.7M | -$114.9M | -$30.4M | -$6.5M | -$31.3M | -$19.6M | $18.0M | -$36.4M | -$20.2M | $1.2M | -$36.0M | -$298.9M | |||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $20.0K | $30.0K | -$47.0K | -$46.0K | -$63.0K | -$71.0K | -$82.0K | -$75.0K | -$115.0K | -$96.0K | |||||
| Comprehensive Income Net Of Tax | -$110.1M | -$104.1M | $12.7M | -$114.9M | -$30.4M | -$6.5M | -$31.3M | -$19.6M | $18.0M | -$36.3M | -$20.1M | $1.2M | -$35.8M | -$298.8M | |||||
| Interest Expense | $1.3M | $1.7M | $1.6M | $1.5M | $1.0M | $945.0K | $871.0K | $867.0K | $1.5M | $2.9M | $2.0M | $2.1M | $2.1M | ||||||
| Other Comprehensive Income Loss Net Of Tax | $93.0K | $244.0K | $631.0K | $2.7M | $300.0K | -$449.0K | $139.0K | -$2.8M | $2.0M | -$5.6M | $513.0K | ||||||||
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | -$0.02 | -$0.02 | $0.00 | $0.02 | $0.00 | $0.00 | $0.00 | |||||||
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | -$0.02 | -$0.02 | $0.00 | $0.02 | $0.00 | $0.00 | $0.00 | |||||||
| Income Loss From Discontinued Operations Net Of Tax | $0.00 | -$236.0K | $307.0K | $429.0K | $1.0M | -$1.6M | -$1.4M | $474.0K | -$4.5M | -$8.2M | |||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $4.0K | $34.0K | $19.0K | $12.0K | -$25.0K | $8.0K | $25.0K | -$52.0K | $115.0K | $0.00 | $0.00 | ||||||||
| Operating Expenses | $1.13B | $724.4M | $691.2M | $654.2M | $494.2M | $797.3M | $425.2M | $322.5M | $294.8M | $296.9M | |||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $89.0K | $210.0K | $612.0K | $2.7M | $325.0K | -$457.0K | $114.0K | -$2.8M | $1.9M | -$5.6M | $513.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $126.7M | $471.0M | $661.8M | $1.04B | $1.09B | -$284.7M | -$232.0M | $41.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $173.7M | $193.9M | $114.3M | $475.9M | $1.05B | $128.2M | $139.2M | $76.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $173.7M | $193.9M | $114.3M | $507.7M | $1.05B | $139.1M | $145.6M | $78.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations | $0.00 | $0.00 | $31.8M | $5.4M | $10.9M | $6.5M | $1.8M | |
| Repayments Of Long Term Debt | $0.00 | $3.8M | $5.0M | $5.0M | $119.9M | $3.0M | $3.6M | |
| Retained Earnings Accumulated Deficit | -$1.98B | -$1.59B | -$1.33B | -$1.06B | -$957.7M | -$551.2M | ||
| Restricted Cash Equivalents Current | $0.00 | $5.6M | $6.8M | $10.6M | $14.8M | $28.4M | ||
| Receivables Net Current | $673.8M | $1.02B | $942.5M | $492.4M | $293.4M | $144.6M | ||
| Property Plant And Equipment Net | $25.4M | $28.2M | $27.6M | $19.9M | $9.2M | $6.5M | ||
| Prepaid Expense And Other Assets Current | $137.8M | $35.1M | $42.5M | $31.6M | $19.0M | $9.6M | ||
| Other Liabilities Noncurrent | $52.3M | $76.1M | $70.4M | $82.5M | $94.3M | $90.1M | ||
| Other Assets Noncurrent | $83.5M | $151.1M | $145.3M | $105.9M | $113.0M | $43.7M | ||
| Long Term Debt Noncurrent | $15.8M | $34.9M | $32.3M | $38.5M | $43.4M | $64.7M | ||
| Liability For Claims And Claims Adjustment Expense | $929.8M | $931.7M | $737.7M | $300.8M | $239.0M | $162.9M | ||
| Liabilities Current | $1.08B | $1.15B | $977.2M | $535.1M | $357.0M | $266.8M | ||
| Liabilities And Stockholders Equity | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B | $446.4M | ||
| Liabilities | $1.14B | $1.26B | $1.08B | $656.9M | $494.7M | $421.6M | ||
| Intangible Assets Net Excluding Goodwill | $65.7M | $72.8M | $63.8M | $18.4M | $55.4M | $60.5M | ||
| Goodwill | $0.00 | $24.1M | $24.1M | $2.5M | $41.5M | $41.5M | ||
| Common Stock Value | $4.1M | $4.1M | $4.1M | $4.1M | $4.0M | $2.5M | ||
| Cash And Cash Equivalents At Carrying Value | $173.7M | $188.2M | $107.6M | $465.3M | $1.04B | $106.8M | ||
| Assets Current | $1.10B | $1.46B | $1.48B | $1.45B | $1.37B | $294.2M | ||
| Assets | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B | $446.4M | ||
| Additional Paid In Capital Common Stock | $2.10B | $2.05B | $1.99B | $2.11B | $2.05B | $264.0M | ||
| Accounts Payable And Accrued Liabilities Current | $127.5M | $220.3M | $239.4M | $177.4M | $112.9M | $97.2M | ||
| Long Term Debt Current | $19.2M | $0.00 | $5.0M | $5.0M | $3.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $306.1M | $408.9M | $500.3M | $574.9M | $676.6M | $689.3M | $872.4M | $880.2M | $1.08B | $1.09B | $1.10B | $1.11B | $1.13B | $1.15B | -$298.2M | -$262.3M | -$248.3M | -$247.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $153.8M | $116.3M | $118.6M | $169.7M | $184.6M | $397.0M | $564.5M | $683.7M | $1.04B | $1.10B | $1.13B | $119.5M | $126.5M | $134.6M | $142.6M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $171.7M | $171.4M | $138.6M | $153.8M | $116.3M | $118.6M | $178.5M | $201.2M | $404.4M | $1.04B | $1.10B | $1.13B | $119.5M | $129.9M | $139.3M | $147.2M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations | $0.00 | $0.00 | $0.00 | $8.9M | $16.6M | $7.4M | $0.00 | $0.00 | $3.4M | $4.7M | $4.6M | ||||||||
| Repayments Of Long Term Debt | $0.00 | $1.3M | $1.3M | $1.3M | $68.6M | $760.0K | |||||||||||||
| Retained Earnings Accumulated Deficit | -$1.79B | -$1.68B | -$1.57B | -$1.48B | -$1.36B | -$1.33B | -$1.10B | -$1.06B | -$1.05B | -$1.01B | -$977.1M | -$956.4M | -$901.0M | -$865.1M | -$566.3M | ||||
| Restricted Cash Equivalents Current | $0.00 | $0.00 | $1.7M | $5.6M | $6.8M | $6.8M | $10.2M | $10.2M | $10.2M | $13.2M | $15.1M | $14.5M | $14.3M | $16.3M | $14.2M | ||||
| Receivables Net Current | $947.2M | $1.05B | $1.24B | $1.37B | $1.44B | $1.57B | $1.35B | $1.42B | $1.00B | $637.7M | $607.6M | $571.9M | $342.5M | $338.4M | $288.8M | ||||
| Property Plant And Equipment Net | $26.1M | $27.4M | $28.1M | $28.2M | $27.8M | $27.5M | $26.2M | $24.4M | $22.1M | $17.9M | $15.8M | $12.5M | $6.5M | $4.6M | $4.8M | ||||
| Prepaid Expense And Other Assets Current | $80.0M | $78.5M | $42.4M | $44.9M | $39.0M | $39.8M | $36.5M | $37.6M | $44.7M | $24.1M | $24.5M | $19.8M | $14.5M | $15.7M | $9.3M | ||||
| Other Liabilities Noncurrent | $50.3M | $54.9M | $57.9M | $72.5M | $72.8M | $71.5M | $70.4M | $75.1M | $78.6M | $87.2M | $91.1M | $91.1M | $90.3M | $93.3M | $91.3M | ||||
| Other Assets Noncurrent | $132.7M | $143.1M | $161.7M | $153.9M | $152.5M | $155.9M | $140.2M | $127.3M | $116.8M | $116.1M | $119.3M | $119.5M | $126.1M | $117.1M | $47.3M | ||||
| Long Term Debt Noncurrent | $0.00 | $0.00 | $0.00 | $34.9M | $27.4M | $29.8M | $34.8M | $36.0M | $37.2M | $39.7M | $40.9M | $42.2M | $44.6M | $45.9M | $99.4M | ||||
| Liability For Claims And Claims Adjustment Expense | $1.06B | $1.04B | $1.11B | $1.19B | $1.10B | $1.27B | $1.01B | $1.10B | $745.6M | $490.8M | $458.0M | $472.3M | $288.1M | $301.0M | $277.0M | ||||
| Liabilities Current | $1.24B | $1.25B | $1.37B | $1.41B | $1.39B | $1.53B | $1.30B | $1.36B | $972.6M | $658.2M | $605.1M | $610.5M | $422.8M | $412.3M | $372.1M | ||||
| Liabilities And Stockholders Equity | $1.60B | $1.71B | $1.93B | $2.09B | $2.16B | $2.32B | $2.28B | $2.35B | $2.17B | $1.87B | $1.84B | $1.86B | $1.69B | $1.70B | $574.0M | ||||
| Liabilities | $1.29B | $1.30B | $1.43B | $1.52B | $1.49B | $1.63B | $1.41B | $1.47B | $1.09B | $785.1M | $737.2M | $743.7M | $557.7M | $551.5M | $562.8M | ||||
| Intangible Assets Net Excluding Goodwill | $75.3M | $65.6M | $68.2M | $73.4M | $74.8M | $72.1M | $92.7M | $94.2M | $92.7M | $60.6M | $62.5M | $53.7M | $58.1M | $58.7M | $61.6M | ||||
| Goodwill | $24.1M | $24.1M | $24.1M | $24.1M | $24.1M | $24.1M | $62.4M | $62.1M | $62.1M | $41.5M | $41.5M | $41.5M | $41.5M | $41.5M | $41.5M | ||||
| Common Stock Value | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M | $3.9M | $3.9M | $2.5M | ||||
| Cash And Cash Equivalents At Carrying Value | $171.7M | $171.4M | $136.9M | $148.2M | $109.5M | $111.7M | $168.3M | $191.0M | $394.2M | $551.3M | $668.6M | $1.02B | $1.08B | $1.11B | $105.3M | ||||
| Assets Current | $1.34B | $1.45B | $1.65B | $1.81B | $1.88B | $2.04B | $1.96B | $2.04B | $1.88B | $1.63B | $1.60B | $1.63B | $1.45B | $1.48B | $417.6M | ||||
| Assets | $1.60B | $1.71B | $1.93B | $2.09B | $2.16B | $2.32B | $2.28B | $2.35B | $2.17B | $1.87B | $1.84B | $1.86B | $1.69B | $1.70B | $574.0M | ||||
| Additional Paid In Capital Common Stock | $2.09B | $2.08B | $2.07B | $2.05B | $2.04B | $2.02B | $1.97B | $1.95B | $2.13B | $2.09B | $2.08B | $2.06B | $2.02B | $2.01B | $265.6M | ||||
| Accounts Payable And Accrued Liabilities Current | $145.5M | $171.9M | $226.7M | $218.5M | $280.9M | $252.5M | $290.6M | $257.8M | $222.1M | $162.4M | $142.0M | $133.1M | $129.7M | $107.6M | $95.1M | ||||
| Long Term Debt Current | $35.0M | $34.9M | $34.9M | $8.8M | $7.5M | $6.3M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $3.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $49.1M | $50.7M | $69.5M | $28.4M | $292.4M | $6.7M | $5.2M |
| Payments To Acquire Property Plant And Equipment | $13.2M | $13.3M | $15.8M | $15.4M | $6.6M | $1.8M | $2.9M |
| Payments To Acquire Intangible Assets | $29.9M | $28.0M | $15.0M | $17.2M | $6.9M | $575.0K | $1.0M |
| Net Cash Provided By Used In Operating Activities | -$105.8M | -$57.8M | -$156.2M | -$130.8M | -$148.2M | -$53.2M | -$103.9M |
| Net Cash Provided By Used In Investing Activities | $88.6M | $139.9M | -$44.0M | -$444.4M | -$90.5M | $22.1M | -$5.1M |
| Net Cash Provided By Used In Financing Activities | -$3.0M | -$2.6M | -$193.1M | $28.1M | $1.15B | $24.6M | $176.3M |
| Depreciation Depletion And Amortization | $28.6M | $24.5M | $20.2M | $13.8M | $14.7M | $14.1M | $41.4M |
| Proceeds From Issuance Of Common Stock | $1.2M | $11.9M | $33.1M | $18.1M | $34.4M | $180.2M | |
| Payments To Acquire Loans Receivable | $13.7M | $19.5M | $6.5M | $82.8M | $3.8M | $1.2M | |
| Adjustments Related To Tax Withholding For Share Based Compensation | $3.1M | $1.6M | $1.8M | $831.0K | |||
| Payments To Acquire Marketable Securities | $60.2M | $12.0M | $114.7M | $458.3M | $0.00 | $0.00 | |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | $0.00 | $0.00 | $2.2M | $500.0K | -$1.3M | $26.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $16.7M | $13.3M | $18.2M | $16.9M | $20.6M | $19.4M | $13.7M | $7.9M | $6.6M | $4.0M | $12.0M | $274.5M | $1.5M | $1.6M | $2.2M | $1.1M | ||
| Payments To Acquire Property Plant And Equipment | $3.8M | $3.1M | $3.7M | $4.0M | $178.0K | $345.0K | ||||||||||||
| Payments To Acquire Intangible Assets | $7.0M | $11.4M | $0.00 | $1.0M | $4.0M | $33.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$32.0M | -$47.8M | -$60.8M | -$23.2M | -$40.8M | -$26.1M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | -$23.1M | $51.4M | -$50.8M | -$8.9M | -$9.1M | $319.0K | ||||||||||||
| Net Cash Provided By Used In Financing Activities | -$161.0K | $559.0K | $8.3M | $13.5M | $30.3M | $27.4M | ||||||||||||
| Depreciation Depletion And Amortization | $6.9M | $5.8M | $4.2M | $3.4M | $3.5M | $3.4M | ||||||||||||
| Proceeds From Issuance Of Common Stock | -$161.0K | $1.8M | $9.6M | $14.8M | $28.1M | |||||||||||||
| Payments To Acquire Loans Receivable | $8.5M | $1.3M | $4.5M | $1.2M | $359.0K | |||||||||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $236.0K | $2.7M | $161.0K | $287.0K | $635.0K | $646.0K | $63.0K | $1.7M | $28.0K | $28.0K | $758.0K | |||||||
| Payments To Acquire Marketable Securities | $47.5M | $0.00 | $30.0M | $0.00 | ||||||||||||||
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | $500.0K | -$3.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 414.0M | 411.0M | 408.9M | 408.2M | 372.9M | 323.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 414.0M | 411.0M | 408.9M | 408.2M | 372.9M | 323.5M |
| Common Stock Shares Authorized | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 500.0M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Outstanding | 414.7M | 412.2M | 406.4M | 412.4M | 400.1M | 249.4M |
| Common Stock Shares Issued | 414.7M | 412.2M | 406.4M | 412.4M | 400.1M | 249.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 414.5M | 413.8M | 412.9M | 411.6M | 411.3M | 408.9M | 405.8M | 410.3M | 413.1M | 411.1M | 407.3M | 402.0M | 391.2M | 377.4M | 325.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 414.5M | 413.8M | 412.9M | 411.6M | 411.3M | 408.9M | 405.8M | 410.3M | 426.6M | 411.1M | 407.3M | 424.1M | 391.2M | 377.4M | 325.7M |
| Common Stock Shares Authorized | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 500.0M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Outstanding | 414.6M | 414.3M | 413.0M | 412.0M | 411.4M | 410.8M | 406.0M | 405.4M | 414.5M | 411.7M | 408.2M | 405.7M | 391.5M | 390.9M | 249.5M |
| Common Stock Shares Issued | 414.6M | 414.3M | 413.0M | 412.0M | 411.4M | 410.8M | 406.0M | 405.4M | 414.5M | 411.7M | 408.2M | 405.7M | 391.5M | 390.9M | 249.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $28.6M | $24.5M | $16.0M | $8.9M | $10.5M | $13.5M | $12.3M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $49.1M | $50.7M | $69.5M | $28.4M | $23.9M | $6.7M | $5.2M |
| Stock Issued During Period Value Stock Options Exercised | $110.0K | $2.8M | $13.7M | $33.9M | $18.1M | $814.0K | |
| Other Noncash Income Expense | $5.5M | -$887.0K | $4.0M | -$3.0M | -$58.0K | $162.0K | $3.1M |
| Discontinued Operation Tax Effect Of Discontinued Operation | $0.00 | $0.00 | $26.0K | -$1.7M | -$2.8M | -$16.2M | |
| Costs And Expenses | $6.40B | $6.35B | $4.55B | $2.49B | $1.89B | ||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Policyholder Benefits And Claims Incurred Health Care | $2.40B | $1.65B | $1.02B | $725.4M | |||
| Other Medical Expenses | $196.1M | $109.5M | $102.3M | $40.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $7.4M | $7.3M | $6.9M | $6.2M | $5.9M | $5.8M | $4.1M | $4.3M | $3.0M | $3.5M | $3.0M | $3.4M | $3.9M | $3.6M | $3.4M | $3.3M | $3.3M | $3.2M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.5M | $15.4M | $16.7M | $13.3M | $18.2M | $16.9M | $20.7M | $19.6M | $13.7M | $7.9M | $6.6M | $4.0M | $12.0M | $6.1M | $1.5M | $1.6M | $2.2M | $1.1M |
| Stock Issued During Period Value Stock Options Exercised | $110.0K | $132.0K | $171.0K | $2.5M | $2.7M | $928.0K | $9.6M | $10.4M | $6.3M | $14.8M | $1.1M | $386.0K | $165.0K | $497.0K | $313.0K | $2.0K | ||
| Other Noncash Income Expense | $2.2M | $472.0K | $1.8M | -$556.0K | -$1.8M | -$837.0K | ||||||||||||
| Discontinued Operation Tax Effect Of Discontinued Operation | $0.00 | $0.00 | $12.0K | $14.0K | $0.00 | $82.0K | $65.0K | $64.0K | $110.0K | $126.0K | $149.0K | |||||||
| Costs And Expenses | $1.57B | $1.51B | $1.55B | $1.58B | $1.53B | $1.61B | $1.18B | $1.10B | $1.05B | $724.4M | $691.2M | |||||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Policyholder Benefits And Claims Incurred Health Care | $972.8M | $618.3M | $587.1M | $566.2M | $414.2M | $442.5M | $360.4M | $260.9M | $220.4M | $247.7M | ||||||||
| Other Medical Expenses | $86.0M | $50.7M | $49.1M | $44.8M | $29.5M | $33.7M | $23.7M | $26.3M | $34.8M | $18.4M |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.